association of interim pet2 response with outcomes in patients with dlbcl
Published 2 years ago • 157 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
1:04
long-term survival outcomes in pts with mf treated with momelotinib vs danazol in the momentum trial
-
3:17
pet imaging to predict treatment outcomes: follow-up from the echelon-2 trial
-
3:02
the role of asparaginase in the treatment of all
-
1:53
canova trial: vendex versus pomdex in patients with r/r multiple myeloma
-
1:21
the correlation between jak2v617f molecular response and efs in patients with early pv
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
4:32
following a lab sample from collection to diagnosis
-
2:09
human’s hematology testimonial video
-
6:53
laboratory assessment of immune functioning | doctors avigan and ludwig | ims 2023
-
1:25
predictors and outcomes of extramedullary disease in multiple myeloma
-
3:46
the impact of cytogenetic risk on outcomes of haploidentical transplantation in r/r aml
-
2:43
interim analysis of the elm-2 study: odronextamab in patients with r/r follicular lymphoma
-
3:39
applications of ai in hemonc: improving diagnosis & predicting outcomes and response to therapy
-
2:22
the challenges with monitoring patients with lymphoma for cardiotoxicity
-
2:15
the role of pet/ct in assessing early treatment response in patients with ndmm
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
2:13
haploidentical sct for the treatment of secondary aml
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
10:42
a detailed overview of the current and emerging gene therapies for hemophilia a & b
-
0:50
insights into the phase ii window-2 trial
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl